Article
The Fibrodysplasia Ossificans Progressiva (FOP) mutation p.R206H in ACVR1 confers an altered ligand response.
Cellular signalling - 1 Jan 2017
Hildebrand Laura, Stange Katja, Deichsel Alexandra, Gossen Manfred, Seemann Petra
Abstract excerpt
Patients with Fibrodysplasia Ossificans Progressiva (FOP) suffer from ectopic bone formation, which progresses during life and results in dramatic movement restrictions. Cause of the disease are point mutations in the Activin A receptor type 1 (ACVR1), with p.R206H being most common. In this study we compared the signalling responses of ACVR1WT and ACVR1R206H to different ligands. ACVR1WT, but not ACVR1R206H...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
